Healthy Skepticism Library
Items published during the years 1980 to 1989
There are 1082 items in the Healthy Skepticism Library that were published during the years 1980 to 1989.
Page 4 of 11 pages ‹ First < 2 3 4 5 6 > Last ›
HSL3616
Tuthill JE.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988; 318:53
HSL3617
Verma S.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988; 318:52
HSL3625
Scott JE.
Ad performance insights
Medical Marketing & Media 1988; 23:(2):32, 34, 36
HSL3628
Bell KD.
Diflunisal advertising [1st of 2 replies]
Medical Journal of Australia 1988; 148:418
HSL3629
Mansfield PR.
Diflunisal advertising
Medical Journal of Australia 1988; 148:418
HSL3646
Hardon A.
Towards rational drug-use in urban primary health care
Drug Monitor 1988; 3:(10):111-119
HSL3661
Anderson A.
Imovane (zopiclone)
New Zealand Medical Journal 1988; 102:647
HSL3662
Arya T.
Popularize trade names through proper advertisements only and not through scientific articles
Journal of the Association of Physicians of India 1988; 37:733
HSL3663
Attanasio AE.
Medical technology in Italy
Lancet 1988; 2:109
HSL3665
Bass M.
Biased Medifacts tape: comment
Canadian Family Physician 1988; 35:2219
HSL9533
Stoker A, Jeffery R.
Pharmaceuticals and health policy: an Indian example.
Soc Sci Med 1988; 27:(5):563-7
HSL9552
Legislation: pharmaceuticals and related products
International Digest of Health Legislation 1988; 39:(4):886-896
HSL9584
Hammond CM.
Peoples's choice: Part 2: Cashing in on consumer research
Pharmaceutical Executive 1988; 8:44, 46, 48
HSL15306
Denig P, Haaijer-Ruskamp FM, Zijsling DH.
How physicians choose drugs.
Soc Sci Med 1988; 27:(12):1381-6
http://www.ncbi.nlm.nih.gov/pubmed/3238456
HSL15543
Pitt L, Nel D.
Pharmaceutical Promotion Tools--Their Relative Importance.
European Journal of Marketing 1988; 22:(5):7-14
http://info.emeraldinsight.com/products/journals/journals.htm?PHPSESSID=l8l21ct3plsq3a52q73jef09v0&id=ejm
HSL19394
Hurwitz M, Caves R
Persuasion or information? promotion and the shares of brand name and generic pharmaceuticals
J Law Econ 1988; 31:299–320
http://ideas.repec.org/a/ucp/jlawec/v31y1988i2p299-320.html
HSL20237
DePaulo PJ
Research on Deception in Marketing Communications: It's relevance to the study of nonverbal behaviour
Journal of Nonverbal Behaviour 1988; 12:(4):253-273
http://www.springerlink.com/content/t0661536617g0h2k/
HSL2336
Soumerai SB, Avorn J, Gortmaker S, Hawley S.
Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene.
Am J Public Health 1987 Dec; 77:(12):1518-23
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=3674250&query_hl=59
HSL9586
AMA official OKs MD dispensing but rejects RPh prescribing
American Druggist 1987 Dec; 197:28, 32, 36
HSL9590
Mossinghoff GJ.
How PMA companies have tightened their control of MD samples
Pharmacy Times 1987 Dec; 53:55-57
HSL3432
Hampton JR, Julian DG.
Role of the pharmaceutical industry in major clinical trials.
Lancet 1987 Nov 28; 2:(8570):1258-9
HSL3421
Crook D.
Drug promotion.
N Z Med J 1987 Nov 25; 100:(836):725
HSL9592
Information for patients about medicines.
Lancet. 1987 Nov 7; 2:(8567):1077-8
HSL3441
Katz RA.
Unhook me.
J Am Acad Dermatol 1987 Nov; 17:(5):
HSL3479
Zuger A.
Promoting Retrovir.
N Engl J Med 1987 Oct 29; 317:(18):1160
HSL3434
Hardy AJ.
Drug promotion.
N Z Med J 1987 Oct 28; 100:(834):667
HSL9598
Revision of rules governing postmarketing reporting of adverse drug reactions
Federal Register 1987 Oct 13; 52:37931-37936
HSL3526
Bell KD.
Drug advertising.
Med J Aust 1987 Oct 5; 147:(7):361
HSL3527
Wing LM, Moulds RF, Shenfield GM, Day RO.
Drug advertising [reply]
Medical Journal of Australia 1987 Oct 5; 147:361
HSL3423
Finucane T.
Drug company-sponsored symposia: pros and cons.
Am J Med 1987 Oct; 83:(4):811-2
HSL3522
MaLAM letter follow up—Bayer
MaLAM Newsletter 1987 Oct;
HSL3523
Re: the promotion of lincomycin and clindamycin
1987 Oct;
HSL3524
Re: the promotion of trimethoprim/sulphamethoxazole/guaiphenesin/ammonium chloride
1987 Oct;
HSL3525
Advertisement of Rx drugs to health professionals
1987 Oct; 17
HSL9591
Chappell SC.
Among top 100 companies: 26 generic firms show aggregate 17% growth
Pharmacy Times 1987 Oct; 53:63-64, 67-69
HSL3450
Lexchin J.
Drug promotion.
N Z Med J 1987 Sep 23; 100:(832):603
HSL3422
de Groot AC, Nater JP, Herxheimer A.
Minoxidil for male-pattern baldness.
Lancet 1987 Sep 5; 2:(8558):563
HSL3519
The IFPMA code: how it works and how it’s working
International Federation of Pharmaceutical Manufacturers Associations 1987 Sep;
www.ifpma.rog/hhhs/welcome.htm
HSL3520
Re: the promotion of flunarizine
1987 Sep;
HSL9596
McCarthy R.
Repackager sees $3 billion market
American Druggist 1987 Sep; 196:62, 64
HSL19897
Chaplin S, Smith JM
Data Sheet Warnings About Drug Safety in Pregnancy
The Lancet 1987 Aug 29; 330:(8557):516
http://www.lancet.com/journals/lancet/article/PIIS0140-6736%2887%2991832-0/fulltext
HSL9595
Denysyk OS.
Five-year prediction made for OTC products
Drug Topics 1987 Aug 17; 131:64-65
HSL14687
Pocock SJ, Hughes MD, Lee RJ.
Statistical problems in the reporting of clinical trials. A survey of three medical journals.
N Engl J Med. 1987 Aug 13; 317:(7):426-32.
http://www.ncbi.nlm.nih.gov/pubmed/3614286
HSL3331
Carter IE.
Canadian Psychiatric Association guidelines in relating to the pharmaceutical industry.
Can J Psychiatry 1987 Aug; 32:(6):476-86
http://web.archive.org/web/20061019043917/http://www.cpa-apc.org/Publications/Position_Papers/Guideline.asp
HSL3417
Buckley EG.
Post-marketing surveillance of new drugs.
J R Coll Gen Pract 1987 Aug; 37:(301):337-8
HSL3512
Crane VS, Jefferson KK, Morgan R.
Rethinking pharmaceutical industry relationships.
Am J Hosp Pharm 1987 Aug; 44:(8):1884-6
HSL3515
DOH proposes regulating of drug ads
Drug Monitor 1987 Aug; 2:(8):3-5
HSL3516
Drug companies trying a facelift
Drug Monitor 1987 Aug; 2:(8):5-6
HSL3517
IFPMA code: trivial requirements ignored by companies
1987 Aug; 1
HSL3518
Organon and anabolic steroids
WEMOS pharma group 1987 Aug;
HSL20513
Eichorn P, Yankauer A
Do authors check their references? A survey of accuracy of references in three public health journals.
Am J Public Health 1987 Aug; 77:(8):1011
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1647239/
HSL3429
Graves J.
Frequent-flyer programs for drug prescribing.
N Engl J Med 1987 Jul 23; 317:(4):252
HSL3437
Hoppin ME.
A university perspective on pharmaceutical and industry support of research.
Am J Clin Nutr 1987 Jul; 46:(1):
HSL3459
Schweigert BS.
University-industry partnership in research.
Am J Clin Nutr 1987 Jul; 46:(1):
HSL3473
Weiss GB, Winslade WJ.
Is post-marketing drug follow-up research or advertising?
IRB 1987 Jul-Aug; 9:(4):10-1
HSL3513
Juergens JP.
Advertising in the American Journal of Hospital Pharmacy.
Am J Hosp Pharm 1987 Jul; 44:(7):1647-51
HSL3514
Zellmer WA.
Prudent and sensible advertising policies.
Am J Hosp Pharm 1987 Jul; 44:(7):1651-3
HSL9569
Alba Romero S
Pharmaceutical industry of Valencia: economic-health context of pharmaceutical specialties
Boletin de la Sociedad Espanola de Historia de la Farmacia 1987 Jul-Dec; 38:401-408
HSL9588
Naude S.
Competition Board report
South African Pharmaceutical Journal 1987 Jul; 54:199
HSL9593
Blauvelt BM, Erlanger DE.
Marketing in the Asian arena: Part 1
Pharmaceutical Executive 1987 Jul; 7:36, 40, 44, 46, 48
HSL9614
George CF.
Telling patients about their medicines.
Br Med J (Clin Res Ed) 1987 Jun 20; 294:(6587):1566-7
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=3113531
HSL2055
Mansfield PR.
Drug Advertising
Med J Aust 1987 Jun 15; 146:(12):660-661
HSL3442
Ketelbey JW.
Fenbufen trial in general practice.
N Z Med J 1987 Jun 10; 100:(825):361
HSL3449
Lexchin J.
Advertisement scrutiny.
Lancet 1987 Jun 6; 1:(8545):1323-4
HSL3416
Bower AD, Burkett GL.
Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices.
J Fam Pract 1987 Jun; 24:(6):612-6
HSL3436
Hilton D.
Promotion by the drug companies--should we accept their bribes?
J R Coll Gen Pract 1987 Jun; 37:(299):270
HSL3438
Hull FM, Marshall T.
Sources of information about new drugs and attitudes towards drug prescribing: an international study of differences between primary care physicians.
Fam Pract 1987 Jun; 4:(2):123-8
HSL3465
Speller DC.
The relationship between the Journal and the pharmaceutical industry.
J Antimicrob Chemother 1987 Jun; 19:(6):711-2
HSL3470
Thomas J 3rd.
National survey of hospital policies on pharmaceutical sales representatives' activities.
Am J Hosp Pharm 1987 Jun; 44:(6):1334-40
HSL3474
Wells F.
Promotion by the drug companies--the industry replies.
J R Coll Gen Pract 1987 Jun; 37:(299):270
HSL3509
MaLAM letter follow up—Janssen
MaLAM Newsletter 1987 Jun; 1-2
HSL3510
MaLAM letter follow up—Parke-Davis
MaLAM Newsletter 1987 Jun; 1
HSL3511
MaLAM letter follow up—Sandoz
MaLAM Newsletter 1987 Jun;
HSL9604
Anderson LJ.
Dealing with the clash beween HMO MDs and pharmacists
Pharmaceutical Executive 1987 Jun; 7:54, 56, 58, 60
HSL9613
Holland K.
Beecham Group Plc
Pharmaceutical Journal 1987 May 30; 238:675-678
HSL3428
Goldfinger SE.
A matter of influence.
N Engl J Med 1987 May 28; 316:(22):1408-9
HSL3460
Seddon TD.
Drug promotion.
N Z Med J 1987 May 27; 100:(824):327
HSL9608
Enter the academic medical representative
Pharmaceutical Journal 1987 May 23; 238:633
HSL3466
Spitzer WO, Hutchinson T, Lane D.
Postmarketing management of drug use: toward rational public policy.
CMAJ 1987 May 15; 136:(10):1022-4
HSL3448
Lauritsen K, Havelund T, Laursen LS, Rask-Madsen J.
Withholding unfavourable results in drug company sponsored clinical trials.
Lancet 1987 May 9; 1:(8541):1091
HSL3468
Stross JK.
Information sources and clinical decisions.
J Gen Intern Med 1987 May-Jun; 2:(3):155-9
HSL3507
IFPMA code advisers
International Federation of Pharmaceutical Manufacturers Associations 1987 May; (1):5
www.ifpma.rog/hhhs/welcome.htm
HSL3508
Piroxicam
1987 May; 1-7
HSL9603
Wertheimer AI.
Prescription drug advertising to the consumer in the United States
International Pharmacy Journal 1987 May-Jul; 1:106-107
HSL9606
Concerning the case of: United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No. G75-558 CA5, W.D. Michigan
Journal Michigan Pharmacist 1987 May; 25:32-33
HSL3427
Godden JO.
Monitoring drug advertisements.
Lancet 1987 Apr 25; 1:(8539):980
HSL3435
Hay DR.
Drug promotion.
N Z Med J 1987 Apr 8; 100:(821):223
HSL3454
Marks I, Mathews A.
Treatment for panic.
Lancet 1987 Apr 4; 1:(8536):805
HSL9602
Madhavan S, Schondelmeyer SW.
Taking it over the counter: Part 1
Pharmaceutical Executive 1987 Apr; 7:78, 80, 82
HSL9612
McCarthy R.
Tremors hit the drug chains
American Druggist 1987 Apr; 195:34, 37-38, 40
HSL9587
Final report on branch resolutions
Pharmaceutical Journal 1987 Mar 28; 238:415
HSL9619
Griffin JP, Sharp JR.
Original pack dispensing.
Br Med J (Clin Res Ed) 1987 Mar 21; 294:(6574):724-5
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=3105709
HSL3447
Laurence DR.
The academic clinical pharmacologist and the Royal College of Physicians Report on the relationship between physicians and the pharmaceutical industry.
Br J Clin Pharmacol 1987 Mar; 23:(3):253-5
HSL3461
Shelley JH.
Relationships between physicians and the pharmaceutical industry: London Royal College of Physicians 1986.
Br J Clin Pharmacol 1987 Mar; 23:(3):257-8
HSL3506
Perri M, Nelson AA Jr.
An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications.
J Health Care Mark 1987 Mar; 7:(1):9-17
HSL9601
Phillips JH.
Dispensing with the RPh's services
American Druggist 1987 Mar; 195:46-48
HSL9607
Jacknowitz AI.
Expiration dating and storage of drugs
US Pharmacist 1987 Mar; 12:36, 38, 40, 106
HSL3504
Dyer C.
The penalties of issuing misleading advertisements.
Br Med J (Clin Res Ed) 1987 Feb 14; 294:(6569):426-7
HSL3505
Editor .
The penalties of issuing misleading advertisements [Editor's response]
British Medical Journal 1987 Feb 14; 294:427
HSL3481
Double standards—some improvements
HAI News 1987 Feb; (33):1-2, 12
Page 4 of 11 pages ‹ First < 2 3 4 5 6 > Last ›
